First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC

Abroad (travel likely)RecruitingPHASE2

Conditions

Small Cell Lung Cancer Extensive Stage

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Union hospital, Wuhan, Hubei, China
Contact: Study coordinator (Xiaorong Dong, Dr.) · xiaorongdong@hust.edu.cn · 02785872859

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

Small Cell Lung Cancer · SCLC · Extensive Stage Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Indianapolis, United States · Iowa City, United States

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

Small Cell Lung Cancer

IsraelRecruitingPHASE2

New Haven, United States · Ocala, United States

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Daphne, United States · Long Beach, United States

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

Small Cell Lung Cancer Extensive Stage

Abroad (travel likely)RecruitingPHASE1, PHASE2

Lone Tree, United States · St Louis, United States